drugset
drugset / Trial / NCT03608072

A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated

NCT03608072 ↗

Phase 1 Completed 36 enrolled Boehringer Ingelheim
RandomizedSequentialDouble-blindTreatment

Summary

The primary objective of the trial is to investigate the safety and tolerability of BI 690517 in healthy Japanese male subjects following oral administration of multiple rising doses over 14 days. Secondary objective is the exploration of the pharmacokinetic(s) (PK) and pharmacodynamic(s) (PD) of BI 690517 in healthy Japanese male subjects after multiple dosing.

Timeline

Start
2018-08-06
Primary completion
2019-01-31
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Vicadrostat Small molecule — Oral

Indications

No indication recorded.